Another interesting perspective is that using AQP4 as a marker of glymphatic functionality could help identify those common neurological diseases in which the system is compromised: for example, this study showed that, compared to controls, patients suffering from MCI or psychiatric disorders displayed a slightly, yet not significantly, increased levels of AQP4 (Fig. 1). The gene discussed is AQP4; the disease is psychiatric disorder.